Moving the boundaries of international collaboration on clinical trials and QoL
26 Mar 2013
In an article appearing in Expert Rev. Pharmacoecon. Outcomes Res. 13 ( 1 ), 43 – 45 ( 2013 )
Andrew Bottomley, Tony Kirby, John Bean, and Julie Walker review the 3rd EORTC Quality of Life, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference held at The European Parliament, Brussels, Belgium, 17–20 October 2012
Related News
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC at the forefront of quality of life research at ISOQOL 2026
21 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
Beyond survival: new CSO and EORTC recommendations call for better reporting of quality of life in adjuvant cancer trials
30 Sep 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
